Orally administrated ascorbic acid suppresses neuronal damage and modifies expression of SVCT2 and GLUT1 in the brain of diabetic rats with cerebral ischemia-reperfusion

• Published in: Nutrients 2014-04, Vol.6 (4), p.1554-1577
• Main Authors: Iwata, Naohiro, Okazaki, Mari, Xuan, Meiyan, Kamiuchi, Shinya, Matsuzaki, Hirokazu, Hibino, Yasuhide
• Format: Article
• Language: English
• Subjects: Acids; Administration, Oral; Animals; Antioxidants; Apoptosis; Apoptosis - drug effects; ascorbic acid; Ascorbic Acid - administration & dosage; Brain - drug effects; Caspase 3; cytokine; Cytokines; Diabetes; diabetes mellitus; Diabetes Mellitus, Experimental - drug therapy; Dietary Supplements; Endothelial Cells - drug effects; Enzymes; Glucose; glucose transporter 1 (GLUT1); Glucose Transporter Type 1 - genetics; Glucose Transporter Type 1 - metabolism; Hyperglycemia; Infarction, Middle Cerebral Artery - drug therapy; Infarction, Middle Cerebral Artery - pathology; Interleukin-1beta - metabolism; Ischemia; Male; middle cerebral artery occlusion and reperfusion; Neurodegeneration; Neurons - drug effects; Oxidative stress; Oxidative Stress - drug effects; Pharmaceutical sciences; proinflammatory; rat; Rats; Rats, Sprague-Dawley; Sodium-Coupled Vitamin C Transporters - genetics; Sodium-Coupled Vitamin C Transporters - metabolism; sodium-dependent vitamin C transporter 2 (SVCT2); Streptozocin; streptozotocin; Tumor Necrosis Factor-alpha - metabolism; Tumor necrosis factor-TNF; Up-Regulation; Veins & arteries; Vitamin C
• ISSN: 2072-6643; 2072-6643
• DOI: 10.3390/nu6041554

Diabetes mellitus is known to exacerbate cerebral ischemic injury. In the present study, we investigated antiapoptotic and anti-inflammatory effects of oral supplementation of ascorbic acid (AA) on cerebral injury caused by middle cerebral artery occlusion and reperfusion (MCAO/Re) in rats with streptozotocin-induced diabetes. We also evaluated the effects of AA on expression of sodium-dependent vitamin C transporter 2 (SVCT2) and glucose transporter 1 (GLUT1) after MCAO/Re in the brain. The diabetic state markedly aggravated MCAO/Re-induced cerebral damage, as assessed by infarct volume and edema. Pretreatment with AA (100 mg/kg, p.o.) for two weeks significantly suppressed the exacerbation of damage in the brain of diabetic rats. AA also suppressed the production of superoxide radical, activation of caspase-3, and expression of proinflammatory cytokines (tumor necrosis factor-α and interleukin-1β) in the ischemic penumbra. Immunohistochemical staining revealed that expression of SVCT2 was upregulated primarily in neurons and capillary endothelial cells after MCAO/Re in the nondiabetic cortex, accompanied by an increase in total AA (AA + dehydroascorbic acid) in the tissue, and that these responses were suppressed in the diabetic rats. AA supplementation to the diabetic rats restored these responses to the levels of the nondiabetic rats. Furthermore, AA markedly upregulated the basal expression of GLUT1 in endothelial cells of nondiabetic and diabetic cortex, which did not affect total AA levels in the cortex. These results suggest that daily intake of AA attenuates the exacerbation of cerebral ischemic injury in a diabetic state, which may be attributed to anti-apoptotic and anti-inflammatory effects via the improvement of augmented oxidative stress in the brain. AA supplementation may protect endothelial function against the exacerbated ischemic oxidative injury in the diabetic state and improve AA transport through SVCT2 in the cortex.